Recent progress in prion and prion-like protein aggregation

被引:5
|
作者
Yi, Chuan-Wei [1 ]
Xu, Wen-Chang [1 ]
Chen, Jie [1 ]
Liang, Yi [1 ]
机构
[1] Wuhan Univ, Coll Life Sci, State Key Lab Virol, Wuhan 430072, Peoples R China
基金
中国国家自然科学基金;
关键词
prion protein; prion-like protein; protein misfolding; physiological environment; macromolecular crowding; AMYOTROPHIC-LATERAL-SCLEROSIS; MISFOLDING CYCLIC AMPLIFICATION; MUTANT SUPEROXIDE-DISMUTASE; SPONGIFORM ENCEPHALOPATHY; SCRAPIE PRION; ALZHEIMERS-DISEASE; TAU AGGREGATION; WILD-TYPE; TRANSMISSION; PROPAGATION;
D O I
10.1093/abbs/gmt052
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Prion diseases and prion-like protein misfolding diseases involve the accumulation of abnormally aggregated forms of the normal host proteins, such as prion protein and Tau protein. These proteins are special because of their self-duplicating and transmissible characteristics. Such abnormally aggregated proteins mainly formed in neurons, cause the neurons dysfunction, and finally lead to invariably fatal neurodegenerative diseases. Prion diseases appear not only in animals, such as bovine spongiform encephalopathy in cattle and scrapie in sheep, but also in humans, such as CreutzfeldtJacob disease, and even the same prion or prion-like proteins can have many different phenotypes. A lot of biological evidence has suggested that the molecular basis for different strains of prions could be hidden in protein conformations, and the misfolded proteins with conformations different from the normal proteins have been proved to be the main cause for protein aggregation. Crowded physiological environments can be imitated in vitro to study how the misfolding of these proteins leads to the diseases in vivo. In this review, we provide an overview of the existing structural information for prion and prion-like proteins, and discuss the post-translational modifications of prion proteins and the difference between prion and other infectious pathogens. We also discuss what makes a misfolded protein become an infectious agent, and show some examples of prion-like protein aggregation, such as Tau protein aggregation and superoxide dismutase 1 aggregation, as well as some cases of prion-like protein aggregation in crowded physiological environments.
引用
收藏
页码:520 / 526
页数:7
相关论文
共 50 条
  • [21] Characterizing Prion-Like Protein Aggregation: Emerging Nanopore-Based Approaches
    Meyer, Nathan
    Torrent, Joan
    Balme, Sebastien
    SMALL METHODS, 2024, 8 (12):
  • [22] The molecular processes underpinning prion-like spreading and seed amplification in protein aggregation
    Meisl, Georg
    Knowles, Tuomas P. J.
    Klenerman, David
    CURRENT OPINION IN NEUROBIOLOGY, 2020, 61 : 58 - 64
  • [23] Heterochromatin aggregation during DNA elimination in Tetrahymena is facilitated by a prion-like protein
    Kataoka, Kensuke
    Mochizuki, Kazufumi
    JOURNAL OF CELL SCIENCE, 2017, 130 (02) : 480 - 489
  • [24] Prion-like spread of protein aggregates in neurodegeneration
    Polymenidou, Magdalini
    Cleveland, Don W.
    JOURNAL OF EXPERIMENTAL MEDICINE, 2012, 209 (05): : 889 - 893
  • [25] Experimental models of prion-like protein propagation
    Hasegawa, Masato
    NEUROPATHOLOGY, 2020, 40 (05) : 460 - 466
  • [26] Polymorphisms within the prion (PrP) and prion-like protein (Doppel) genes in AD
    Golanska, E
    Hulas-Bigoszewska, K
    Rutkiewicz, E
    Styczynska, M
    Peplonska, B
    Barcikowska, M
    Bratosiewicz-Wasik, J
    Liberski, PP
    NEUROLOGY, 2004, 62 (02) : 313 - 315
  • [27] Prion and Prion-Like Protein Strains: Deciphering the Molecular Basis of Heterogeneity in Neurodegeneration
    Scialo, Carlo
    De Cecco, Elena
    Manganotti, Paolo
    Legname, Giuseppe
    VIRUSES-BASEL, 2019, 11 (03):
  • [28] The effects of glutamine/asparagine content on aggregation and heterologous prion induction by yeast prion-like domains
    Shattuck, Jenifer E.
    Waechter, Aubrey C.
    Ross, Eric D.
    PRION, 2017, 11 (04) : 249 - 264
  • [29] Emergence and evolution of yeast prion and prion-like proteins
    Lu An
    David Fitzpatrick
    Paul M. Harrison
    BMC Evolutionary Biology, 16
  • [30] Editorial: Prion and prion-like proteins in neurodegenerative diseases
    Toni, Mattia
    Eleuteri, Simona
    FRONTIERS IN NEUROSCIENCE, 2022, 16